Method of inactivating reproducible filterable pathogens in bloo

Details Method of inactivating reproducible filterable pathogens in bloo Method of inactivating reproducible filterable pathogens in bloo

1989-01-03

1990-02-27

Rosen, Sam

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

424101, 514 7, 514 8, A61K 3702, A61K 3516

Patent

active

049046411

ABSTRACT:
There is disclosed a method of inactivating reproducible filterable pathogens in blood plasma products by applying elevated temperatures. The blood plasma products are heat treated in a solid state in a closed inactivation container in the presence of specific amounts of water and organic compounds, provided that the water substantially remains physically bound to the blood plasma products, while the organic compound is present in a gaseous form in the atmosphere. The water content of the blood plasma products is 0.08 to 0.40. The concentration of the organic compounds in the gaseous phase is 0.01 to 10 g per liter of container volume.

REFERENCES:
patent: 3041242 (1962-06-01), Barr
patent: 4379085 (1983-04-01), Williams et al.
patent: 4490361 (1984-12-01), Heldebrant
patent: 4522751 (1985-06-01), Linnau et al.
patent: 4640834 (1987-02-01), Eibl et al.

Affiliated with

Also associated with

Rating

Method of inactivating reproducible filterable pathogens in bloo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inactivating reproducible filterable pathogens in bloo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inactivating reproducible filterable pathogens in bloo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-174231